These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30761948)

  • 1. Invasive fungal infection in crtically ill patients: hurdles and next challenges.
    José P; Alvarez-Lerma F; Maseda E; Olaechea P; Pemán J; Soriano C; Zaragoza R
    J Chemother; 2019 Apr; 31(2):64-73. PubMed ID: 30761948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
    Bassetti M; Garnacho-Montero J; Calandra T; Kullberg B; Dimopoulos G; Azoulay E; Chakrabarti A; Kett D; Leon C; Ostrosky-Zeichner L; Sanguinetti M; Timsit JF; Richardson MD; Shorr A; Cornely OA
    Intensive Care Med; 2017 Sep; 43(9):1225-1238. PubMed ID: 28255613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients.
    Leonart LP; Tonin FS; Ferreira VL; Penteado STS; Wiens A; Motta FA; Pontarolo R
    J Clin Pharm Ther; 2017 Oct; 42(5):530-538. PubMed ID: 28620958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.
    Wang Y; Xie J; Xing Y; Chen L; Li Y; Meng T; Dong W; Wang X; Dong Y
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Changing Epidemiology of Invasive Fungal Infections.
    Enoch DA; Yang H; Aliyu SH; Micallef C
    Methods Mol Biol; 2017; 1508():17-65. PubMed ID: 27837497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological profile and sensitivity pattern of isolates causing invasive fungal infection vs. colonizing isolates in non-neutropenic critically ill patients].
    Serrano R; Gimeno A; Plumed L; Pemán J; Alvarez B; Plazas J; Caturla J
    Rev Iberoam Micol; 2013 Jan; 30(1):14-20. PubMed ID: 22749973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive fungal infections in critically ill patients: A prospective study from a tertiary care hospital in India.
    Durga CS; Gupta N; Soneja M; Bhatt M; Xess I; Jorwal P; Singh G; Ray A; Nischal N; Ranjan P; Biswas A; Wig N
    Drug Discov Ther; 2018; 12(6):363-367. PubMed ID: 30674771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?
    Utsumi M; Umeda Y; Yagi T; Nagasaka T; Shinoura S; Yoshida R; Nobuoka D; Kuise T; Fuji T; Takagi K; Takaki A; Fujiwara T
    Dig Surg; 2019; 36(1):59-66. PubMed ID: 29649828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
    Pomares H; Arnan M; Sánchez-Ortega I; Sureda A; Duarte RF
    Mycoses; 2016 Aug; 59(8):516-9. PubMed ID: 27027972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
    Sarina B; Mariotti J; Bramanti S; Morabito L; Crocchiolo R; Rimondo A; Tordato F; Pocaterra D; Casari E; De Philippis C; Carlo-Stella C; Santoro A; Castagna L
    Transpl Infect Dis; 2018 Aug; 20(4):e12906. PubMed ID: 29668124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
    Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M;
    JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
    Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA
    Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer.
    Colombo AL; de Almeida Júnior JN; Slavin MA; Chen SC; Sorrell TC
    Lancet Infect Dis; 2017 Nov; 17(11):e344-e356. PubMed ID: 28774702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individualized antifungal therapy in critically ill patients with invasive fungal infection].
    Zaragoza R; Maseda E; Pemán J
    Rev Iberoam Micol; 2021; 38(2):68-74. PubMed ID: 34301466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antifungal treatment for suspected or proved candidiasis in the critically ill].
    Massanet P; Jung B; Molinari N; Villiet M; Moulaire V; Roch-Torreilles I; Jaber S; Reynes J; Corne P
    Ann Fr Anesth Reanim; 2014 Apr; 33(4):232-9. PubMed ID: 24684836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER-IFI study.
    Viale PL; Mirandola S; Natalini C; Esposti LD; Dovizio M; Veronesi C; Forcina G; Navalesi P; Boscolo A
    Mycoses; 2024 Aug; 67(8):e13779. PubMed ID: 39101705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal stewardship considerations for adults and pediatrics.
    Hamdy RF; Zaoutis TE; Seo SK
    Virulence; 2017 Aug; 8(6):658-672. PubMed ID: 27588344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring European Consensus About the Remaining Treatment Challenges and Subsequent Opportunities to Improve the Management of Invasive Fungal Infection (IFI) in the Intensive Care Unit.
    Hoenigl M; Enoch DA; Wichmann D; Wyncoll D; Cortegiani A
    Mycopathologia; 2024 May; 189(3):41. PubMed ID: 38704761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.